234 related articles for article (PubMed ID: 33827972)
1. Urolithin A improves muscle function by inducing mitophagy in muscular dystrophy.
Luan P; D'Amico D; Andreux PA; Laurila PP; Wohlwend M; Li H; Imamura de Lima T; Place N; Rinsch C; Zanou N; Auwerx J
Sci Transl Med; 2021 Apr; 13(588):. PubMed ID: 33827972
[TBL] [Abstract][Full Text] [Related]
2. IP
Valladares D; Utreras-Mendoza Y; Campos C; Morales C; Diaz-Vegas A; Contreras-Ferrat A; Westermeier F; Jaimovich E; Marchi S; Pinton P; Lavandero S
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3685-3695. PubMed ID: 30251688
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
[TBL] [Abstract][Full Text] [Related]
4. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
[TBL] [Abstract][Full Text] [Related]
5. Impairments in left ventricular mitochondrial bioenergetics precede overt cardiac dysfunction and remodelling in Duchenne muscular dystrophy.
Hughes MC; Ramos SV; Turnbull PC; Edgett BA; Huber JS; Polidovitch N; Schlattner U; Backx PH; Simpson JA; Perry CGR
J Physiol; 2020 Apr; 598(7):1377-1392. PubMed ID: 30674086
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated Autophagy and Mitophagy in a Mouse Model of Duchenne Muscular Dystrophy Remain Unchanged Following Heme Oxygenase-1 Knockout.
Mucha O; Kaziród K; Podkalicka P; Rusin K; Dulak J; Łoboda A
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008897
[TBL] [Abstract][Full Text] [Related]
7. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
8. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol Decreases Oxidative Stress by Restoring Mitophagy and Improves the Pathophysiology of Dystrophin-Deficient
Sebori R; Kuno A; Hosoda R; Hayashi T; Horio Y
Oxid Med Cell Longev; 2018; 2018():9179270. PubMed ID: 30510631
[TBL] [Abstract][Full Text] [Related]
10. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
[TBL] [Abstract][Full Text] [Related]
11. A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys.
St Andre M; Johnson M; Bansal PN; Wellen J; Robertson A; Opsahl A; Burch PM; Bialek P; Morris C; Owens J
Skelet Muscle; 2017 Nov; 7(1):25. PubMed ID: 29121992
[TBL] [Abstract][Full Text] [Related]
12. Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy.
Mantuano P; Sanarica F; Conte E; Morgese MG; Capogrosso RF; Cozzoli A; Fonzino A; Quaranta A; Rolland JF; De Bellis M; Camerino GM; Trabace L; De Luca A
Biochem Pharmacol; 2018 Aug; 154():89-103. PubMed ID: 29684379
[TBL] [Abstract][Full Text] [Related]
13. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
[TBL] [Abstract][Full Text] [Related]
14. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.
Whitehead NP; Kim MJ; Bible KL; Adams ME; Froehner SC
Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12864-9. PubMed ID: 26417069
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial content is preserved throughout disease progression in the mdx mouse model of Duchenne muscular dystrophy, regardless of taurine supplementation.
Barker RG; Wyckelsma VL; Xu H; Murphy RM
Am J Physiol Cell Physiol; 2018 Apr; 314(4):C483-C491. PubMed ID: 29351413
[TBL] [Abstract][Full Text] [Related]
16. SU9516 Increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy.
Sarathy A; Wuebbles RD; Fontelonga TM; Tarchione AR; Mathews Griner LA; Heredia DJ; Nunes AM; Duan S; Brewer PD; Van Ry T; Hennig GW; Gould TW; Dulcey AE; Wang A; Xu X; Chen CZ; Hu X; Zheng W; Southall N; Ferrer M; Marugan J; Burkin DJ
Mol Ther; 2017 Jun; 25(6):1395-1407. PubMed ID: 28391962
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy.
Gehrig SM; van der Poel C; Hoeflich A; Naim T; Lynch GS; Metzger F
Growth Horm IGF Res; 2012 Apr; 22(2):69-75. PubMed ID: 22424862
[TBL] [Abstract][Full Text] [Related]
18. Dental pulp stem cells can improve muscle dysfunction in animal models of Duchenne muscular dystrophy.
Nitahara-Kasahara Y; Kuraoka M; Guillermo PH; Hayashita-Kinoh H; Maruoka Y; Nakamura-Takahasi A; Kimura K; Takeda S; Okada T
Stem Cell Res Ther; 2021 Jan; 12(1):78. PubMed ID: 33494794
[TBL] [Abstract][Full Text] [Related]
19. Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy.
Kalkan H; Pagano E; Paris D; Panza E; Cuozzo M; Moriello C; Piscitelli F; Abolghasemi A; Gazzerro E; Silvestri C; Capasso R; Motta A; Russo R; Di Marzo V; Iannotti FA
EMBO Mol Med; 2023 Mar; 15(3):e16225. PubMed ID: 36594243
[TBL] [Abstract][Full Text] [Related]
20. AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy.
Abou-Samra M; Selvais CM; Boursereau R; Lecompte S; Noel L; Brichard SM
J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):518-533. PubMed ID: 31965757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
